Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy

Nasha Qiu; Yun Liu; Qi Liu; Yanzuo Chen; Limei Shen; Mengying HU; Xuefei Zhou; Youqing Shen; Jianqing Gao; Leaf Huang

doi:10.1016/j.biomaterials.2020.120604

journal article Feb 01, 2021

Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy

Nasha Qiu Yun Liu

Qi Liu

Yanzuo Chen Limei Shen Mengying HU

Biomaterials Vol. 269 pp. 120604 · Elsevier BV

View at Publisher Save 10.1016/j.biomaterials.2020.120604

Topics

No keywords indexed for this article. Browse by subject →

References

42

[1]

Sandru "Survival rates of patients with metastatic malignant melanoma" J. Med. Life (2014)

[2]

Antohe "Tumor infiltrating lymphocytes: the regulator of melanoma evolution" Oncol. Lett. (2019)

[3]

Weiss "Immunotherapy of melanoma: facts and hopes" Clin. Canc. Res. (2019) 10.1158/1078-0432.ccr-18-1550

[4]

Ribas "Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial" Lancet Oncol. (2015) 10.1016/s1470-2045(15)00083-2

[5]

Kroemer "Immunogenic cell death in cancer therapy" (2013)

[6]

Kepp "Consensus guidelines for the detection of immunogenic cell death" OncoImmunology (2014) 10.4161/21624011.2014.955691

[7]

Obeid "Calreticulin exposure dictates the immunogenicity of cancer cell death" Nat. Med. (2007) 10.1038/nm1523

[8]

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek et al.

Nature Reviews Cancer 2012 10.1038/nrc3380

[9]

Bommareddy "Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma" OncoImmunology (2019) 10.1080/2162402x.2019.1591875

[10]

Chen "Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy" Adv. Mater. (2019) 10.1002/adma.201802228

[11]

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Christina Twyman-Saint Victor, Andrew J. Rech, Amit Maity et al.

Nature 2015 10.1038/nature14292

[12]

Vanpouille-Box "DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity" Nat. Commun. (2017) 10.1038/ncomms15618

[13]

Mathew "Combining chemotherapy with PD-1 blockade in NSCLC" Pharmacol. Therap. (2018) 10.1016/j.pharmthera.2018.01.003

[14]

Rios-Doria "Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models" Neoplasia (2015) 10.1016/j.neo.2015.08.004

[15]

Feng "Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment" Adv. Mater. (2018) 10.1002/adma.201803001

[16]

Liu "Crizotinib-induced immunogenic cell death in non-small cell lung cancer" Nat. Commun. (2019) 10.1038/s41467-019-09415-3

[17]

Liu "Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death" OncoImmunology (2019) 10.1080/2162402x.2019.1596652

[18]

Galluzzi "Immunological effects of conventional chemotherapy and targeted anticancer agents" Canc. Cell (2015) 10.1016/j.ccell.2015.10.012

[19]

Bommareddy "MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation" Sci. Transl. Med. (2018) 10.1126/scitranslmed.aau0417

[20]

Song "Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap" Nat. Commun. (2018) 10.1038/s41467-018-04605-x

[21]

Li "Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study" Cell Death Dis. (2015) 10.1038/cddis.2014.543

[22]

Sethi "Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappa B-regulated gene products and TAK1-mediated NF-kappa B activation" Blood (2007) 10.1182/blood-2006-10-050807

[23]

Feng "ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3 beta in the signal network" Cell Death Dis. (2013) 10.1038/cddis.2013.222

[24]

Liu "Nanocarrier-mediated chemo-immunotherapy arrested cancer progression and induced tumor dormancy in desmoplastic melanoma" ACS Nano (2018) 10.1021/acsnano.8b01890

[25]

Hu "Celastrol-induced Nur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy" Mol. Cell. (2017) 10.1016/j.molcel.2017.03.008

[26]

Lee "Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy" BMB Rep (2014) 10.5483/bmbrep.2014.47.12.069

[27]

Yang "Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages" Biochem. Biophys. Res. Commun. (2018) 10.1016/j.bbrc.2018.03.224

[28]

Hou "Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma" Theranostics (2018) 10.7150/thno.24821

[29]

Gowrishankar "Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-kappa B" PloS One (2015) 10.1371/journal.pone.0123410

[30]

Kfoury "AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress" EMBO J. (2018) 10.15252/embj.201797673

[31]

Madonna "NF-kappa B as potential target in the treatment of melanoma" J. Transl. Med. (2012) 10.1186/1479-5876-10-53

[32]

Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

Libing Zhang, Richard A. Morgan, Joal D. Beane et al.

Clinical Cancer Research 2015 10.1158/1078-0432.ccr-14-2085

[33]

Rosenberg "IL-2: the first effective immunotherapy for human cancer" J. Immunol. (2014) 10.4049/jimmunol.1490019

[34]

Yu "Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment" Nat. Rev. Immunol. (2007) 10.1038/nri1995

[35]

Warren "NK cells and apoptosis" Immunol. Cell Biol. (1999) 10.1046/j.1440-1711.1999.00790.x

[36]

Caron "Human NK cells constitutively express membrane TNF-alpha (mTNF alpha) and present mTNF alpha-dependent cytotoxic activity" Eur. J. Immunol. (1999) 10.1002/(sici)1521-4141(199911)29:11<3588::aid-immu3588>3.0.co;2-o

[37]

Fauriat "Regulation of human NK-cell cytokine and chemokine production by target cell recognition" Blood (2010) 10.1182/blood-2009-08-238469

[38]

Jiang "Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape" Mol. Canc. (2019) 10.1186/s12943-018-0928-4

[39]

Yee "MicroRNA-155 induction via TNF- and IFN- suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells" J. Biol. Chem. (2017) 10.1074/jbc.m117.809053

[40]

Yang "Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice" Canc. Res. (2006) 10.1158/0008-5472.can-05-4529

[41]

Wei "Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts" Oncotarget (2014) 10.18632/oncotarget.2171

[42]

Lin "Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition" Front. Pharmacol. (2016) 10.3389/fphar.2015.00320

Cited By

87

Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products

Le-le Zhang, Du-Juan Zhang · 2024

Phytomedicine

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

Mina Amiri, Ommoleila Molavi · 2023

Cancer Cell International

Metrics

87

Citations

42

References

Details

Published: Feb 01, 2021
Vol/Issue: 269
Pages: 120604
License: View

Authors

Beijing Tongren Hospital

Department of Pharmacology School of Medicine Zhejiang University Hangzhou Zhejiang 310058 China

Funding

National Institutes of Health

National Natural Science Foundation of China

Cite This Article

Nasha Qiu, Yun Liu, Qi Liu, et al. (2021). Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials, 269, 120604. https://doi.org/10.1016/j.biomaterials.2020.120604

Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy

You May Also Like